Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.
- DOI
- 10.2196/79865
- Published
- 2026 Mar 17
- Container
- JMIR research protocols
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2196/79865,
title = {Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.},
author = {Sharma S and Ganguly S and Murugadoss K and Kayal S and Keerthivasagam S and Ramamoorthy J and Singh A and Pushpam D and Mathaiyan J and Gloor Y and Baleydier F and Ansari M and Bakhshi S and Dubashi B and Uppugunduri CRS},
year = {2026},
journal = {JMIR research protocols},
doi = {10.2196/79865},
url = {https://doi.org/10.2196/79865}
}RIS
TY - JOUR TI - Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study. AU - Sharma S AU - Ganguly S AU - Murugadoss K AU - Kayal S AU - Keerthivasagam S AU - Ramamoorthy J AU - Singh A AU - Pushpam D AU - Mathaiyan J AU - Gloor Y AU - Baleydier F AU - Ansari M AU - Bakhshi S AU - Dubashi B AU - Uppugunduri CRS PY - 2026 JO - JMIR research protocols DO - 10.2196/79865 UR - https://doi.org/10.2196/79865 ER -
APA
S, S., S, G., K, M., S, K., S, K., J, R., A, S., D, P., J, M., Y, G., F, B., M, A., S, B., B, D., & CRS, U. (2026). Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.. JMIR research protocols. https://doi.org/10.2196/79865
Source records
- pubmed · retrieved 2026-09-26T16:40:57.296Z